Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

NCT02744339 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Hypertension, Pulmonary
Heart Failure With Normal Ejection Fraction

Interventions

DRUG: Riociguat
DRUG: Placebo

Sponsor

Medical University of Vienna